19 June 2013
Keywords: gsk, licenses, speracor, insomnia, drug, world, giant
Article | 17 September 2007
World drug giant GlaxoSmithKline has licensed USA-based Sepracor's eszopiclone product for all markets worldwide, excluding the USA,
Canada, Mexico and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 September 2007
18 June 2013
© 2013 thepharmaletter.com